Bressolle F, Bres J, Brun S, Rechencq E
J Chromatogr. 1979 Jul 1;174(2):421-33. doi: 10.1016/s0021-9673(00)86016-1.
Assays are proposed for sulpiride and other benzamides, vincamine and naftazone in plasma (or blood) and urine with direct UV reflectance spectrophotometry on this are applied directly on TLC along with a calibration curve on each plate. Plasma (or total blood) samples are extracted, and an internal standard is added before aplication; slopes of the obtained calibration curves do not change significantly from plate to plate, thus allowing several determinations on the same plate. The sensitivity is 2 microgram in a 1-ml sample (amount applied 30 ng) for sulpiride and related compounds and about the same for vincamine. Naftazone is determined in plasma with simultaneous reflectance and transmittance spectrophotometric measurements at 520 nm on chromatoplates sprayed with lead acetate, the sensitivity reached is 10 ng in a 1-ml sample (amount applied 0.5 ng). For all drugs studied, the proposed techniques are specific, reliable and sensitive enough and can be used to perform pharmacokinetic studies in human or in animal after administration of doses in the therapeutic range.
本文提出了用直接紫外反射分光光度法测定血浆(或全血)和尿液中舒必利及其他苯甲酰胺类、长春胺和萘他唑酮的方法。在此方法中,校准曲线直接应用于薄层色谱(TLC)的每块板上。血浆(或全血)样品经提取后,在点样前加入内标物;所得校准曲线的斜率在不同板之间无显著变化,因此可在同一块板上进行多次测定。对于舒必利及相关化合物,1 ml样品(点样量为30 ng)中的检测限为2 μg,长春胺的检测限与之相近。萘他唑酮在血浆中的测定是在喷有醋酸铅的色谱板上,于520 nm处同时进行反射和透射分光光度测量,1 ml样品(点样量为0.5 ng)中的检测限为10 ng。对于所有研究的药物,所提出的技术具有足够的特异性、可靠性和灵敏度,可用于在给予治疗范围内剂量后对人和动物进行药代动力学研究。